Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2260405

N#Cc1ccc(-[n+]2ccc(-c3cc[n+](C(c4ccccc4)P(=O)(O)O)cc3)cc2)cc1.[Cl-].[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.39
▸ PTPN5 P54829 2/20 0.36
▸ ACP3 P15309 3/20 0.35
▸ S1PR4 O95977 2/20 0.34
▸ S1PR3 Q99500 2/20 0.34
▸ MMP8 P22894 1/20 0.33
▸ MMP14 P50281 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ PRSS1 P07477 2/20 0.32
▸ CTSG P08311 1/20 0.32
▸ CTRB1 P17538 1/20 0.32
▸ CMA1 P23946 1/20 0.32
▸ LSS P48449 1/20 0.31
▸ EEF2K O00418 1/20 0.31
▸ F2 P00734 1/20 0.31
▸ PLG P00747 1/20 0.31
▸ PLAU P00749 1/20 0.31
▸ KLKB1 P03952 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2264057 0.87 ACP3 (0.41) ACP3MMP8MMP14CA14SRC
Hydrochloric Acid SCHEMBL2259577 0.84 ACP3 (0.38) PTPN5ACP3MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2264240 0.84 ACP3 (0.37) MMP2ACP3MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2259347 0.82 MMP2 (0.43) MMP2ACP3MMP8MMP14CA14
SCHEMBL4334656 0.81 MMP2 (0.44) MMP2ACP3MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2259936 0.80 MMP2 (0.39) MMP2PTPN5MEN1KMT2A
Hydrochloric Acid SCHEMBL2892897 0.78 ACP3 (0.39) ACP3MMP8MMP14CA14SRC
Hydrochloric Acid SCHEMBL3922779 0.77 ACP3 (0.32) ACP3MMP8MMP14CA14SRC
Hydrochloric Acid SCHEMBL2899630 0.74 ACP3 (0.43) ACP3MMP8MMP14CA14SRC
Hydrochloric Acid SCHEMBL3928802 0.74 ACP3 (0.41) ACP3MMP8MMP14CA14SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US claimed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US claimed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP claimed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO claimed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP claimed
US-8999430-B2 Method of manufacturing display element KONICA MINOLTA HOLDINGS, INC. (JP) 2015-04-07 — — US disclosed
EP-2149816-B1 METHOD OF MANUFACTURING AN ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2014-05-07 — — EP disclosed
US-8014056-B2 Display element and method of driving the same KONICA MINOLTA HOLDINGS, INC. (JP) 2011-09-06 — — US disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 — — US disclosed
US-20100166946-A1 METHOD OF MANUFACTURING DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2010-07-01 — — US disclosed
US-20100091353-A1 DISPLAY ELEMENT AND METHOD OF DRIVING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2010-04-15 — — US disclosed
EP-2149816-A1 METHOD FOR PRODUCTION OF DISPLAY ELEMENT Konica Minolta Holdings, Inc. (JP) 2010-02-03 — — EP disclosed
US-20090316249-A1 ELECTROCHROMIC DISPLAY DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-12-24 — — US disclosed
EP-2096490-A1 DISPLAY ELEMENT AND METHOD OF DRIVING THE SAME Konica Minolta Holdings, Inc. (JP) 2009-09-02 — — EP disclosed
US-7567371-B2 Electrochromic compounds NTERA LIMITED (IE) 2009-07-28 — — US disclosed
EP-2040115-A1 ELECTROCHROMIC DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2009-03-25 — — EP disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP disclosed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED MMP2 2943/4885PTPN5 2907/4885ACP3 2868/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED MMP2 2943/4885PTPN5 2907/4885ACP3 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback